Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 5, Number 7, November 2005

Book review

Review article

Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
pp. 471-488(18)
Authors: Pakneshan, Pouya; Szyf, Moshe; Rabbani, Shafaat A.


Cancer Therapy Through Control of Cell Migration
pp. 505-518(14)
Author: Levin, Eugene G.


Inhibition of Angiogenesis by Cleaved High Molecular Weight Kininogen (HKa) and HKa Domain 5
pp. 519-528(10)
Authors: McCrae, Keith R.; Donate, Fernando; Merkulov, Sergei; Sun, Danyu; Qi, Xiaoping; Shaw, David E.


Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors
pp. 529-541(13)
Authors: Daniel, Kenyon G.; Kuhn, Deborah J.; Kazi, Aslamuzzaman; Dou, Q. P.


Control of Copper Status for Cancer Therapy
pp. 543-549(7)
Authors: Goodman, Vicki L.; Brewer, George J.; Merajver, Sofia D.


Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose
pp. 551-559(9)
Authors: Shaked, Yuval; Bocci, Guido; Munoz, Raquel; Man, Shan; Ebos, John M.L.; Hicklin, Daniel J.; Bertolini, Francesco; D'Amato, Robert; Kerbel, Robert S.


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more